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Abstract
Purpose—The purpose of this study was to determine whether combining a structural measure 
with contrast sensitivity perimetry (CSP), which has lower test-retest variability than static 
automated perimetry (SAP), reduces prediction error with two models of glaucoma progression.
Methods—In this retrospective analysis, eyes with 5 visits with rim area (RA), SAP and CSP 
measures were selected from two datasets. Twenty-six eyes with open-angle glaucoma were 
included in the analyses. For CSP and SAP, mean sensitivity (MS) was obtained by converting the 
sensitivity values at each location from decibel (SAP) or log units (CSP) to linear units, and then 
averaging all values. MS and RA values were expressed as percent of mean normal based on 
independent normative data. Data from the first 3 and 4 visits were used to calculate errors in 
prediction for the 4th and 5th visits, respectively. Prediction errors were obtained for simple linear 
regression and the dynamic structure-function (DSF) model.
Results—With linear regression, the median prediction errors ranged from 6% to 17% when 
SAP MS and RA were used and from 9% to 17% when CSP MS and RA were used. With the DSF 
model, the median prediction errors ranged from 6% to 11% when SAP MS and RA were used 
and from 7% to 16% when CSP MS and RA were used.
Conclusions—The DSF model had consistently lower prediction errors than simple linear 
regression. The lower test-retest variability of CSP in glaucomatous defects did not, however, 
result in lower prediction error.
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INTRODUCTION
Glaucoma is a group of optic neuropathies in which progressive degeneration of the retinal 
ganglion cells and their axons results in visual field loss.1 Detecting the earliest signs of 
glaucomatous progression is important in clinical practice in order to modify or intensify the 
treatment of glaucoma to prevent irreversible pathologic changes.2 Progression of the 
disease can be detected by observing structural, as well as functional change.3 The nature 
and mechanism of the relationship between structure and function in glaucoma is not yet 
fully understood.4 Structural and functional measurements may each provide unique 
information regarding the presence of the disease and its progression.5
Attempts have been made to improve sensitivity to detect glaucoma progression. Several 
models such as machine learning classifiers and Bayesian models have been developed to 
identify progression based on combined structural and functional measurements.6,7 The 
Bayesian approach has been shown to provide significantly better performance for detecting 
glaucoma progression compared to ordinary least square linear regression.8,9 The dynamic 
structure-function model (DSF) is another model developed to monitor progression that uses 
structural and functional data jointly.10 We previously showed that the DSF model has lower 
prediction error compared to ordinary linear regression when short follow-up series are used. 
These results were obtained using rim area (RA) as the structural parameter and mean of 
sensitivity values expressed in linear units (MS) obtained from static automated perimetry 
(SAP) as the functional parameter.
SAP is widely used for visual field assessment and is the current clinical standard. 
Nevertheless, its high test-retest variability in areas of glaucomatous defects poses a 
challenge when monitoring glaucoma progression.11 For SAP, it has been calculated that a 
reduction of about 20% in test-retest variability is necessary to detect progression one visit 
earlier and that a reduction of about 40% is necessary to detect progression a year earlier.12
In part to address the drawbacks of SAP and reduce its variability, other tests of visual 
function have been developed using different types of stimuli13,14 or stimulus of different 
sizes.15 Contrast sensitivity perimetry (CSP) is one such test that uses sinusoidal stimuli to 
achieve low variability in areas of glaucomatous defects. CSP uses sinusoidal stimuli with 
peak spatial frequencies similar to those used in frequency-doubling technology perimetry 
(FDP), but without the sharp stimulus edges and high temporal frequencies used in FDP.14 
CSP has been shown to have lower test-retest variability in damaged regions of the visual 
field, as well as better agreement with RA compared to SAP.14 This may lead to earlier 
detection of glaucoma progression. The aim of this study was to assess the prediction 
accuracy of the DSF model when CSP is used as a functional test compared to SAP. Given 
the lower test-retest variability of CSP compared to SAP, we hypothesized that using it as 
the functional test would improve the prediction accuracy of the DSF model.
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METHODS
Participants
This study was a retrospective data analysis based on the two datasets reported in Swanson 
et al and Hot et al.14,16 From these datasets, we selected patients with glaucoma who had at 
least six visits with HRT, SAP and CSP-1 data (n=19) and HRT, SAP and CSP-2 data 
(n=20). Some patients were included in both datasets (n=13) (a total of 26 eyes of 26 
patients were selected across the two datasets). Patients were recruited from Indiana 
University School of Optometry and from the State University of New York College of 
Optometry. The 19 patients tested with CSP-1 had mean (± SD) age of 66 ± 7 years of age at 
baseline. The 20 patients tested with CSP-2 had mean (± SD) age of 69 ± 7 years of age at 
baseline. Overall, 46% of the patients were females. The study adhered to the tenets of the 
declaration of Helsinki, was HIPAA-compliant and approved by all appropriate institutional 
review boards. Informed consent was obtained from each participant after the goals and 
procedures of the study were explained.
Inclusion criteria—All patients had a diagnosis of glaucoma, clear ocular media, 
spherical correction within 6 diopters (D) and cylindrical correction within 3 D, intra-ocular 
pressure below 22 mmHg under treatment, and visual field defects consistent with a 
diagnosis of glaucoma. The diagnosis of glaucoma was established based on medical and 
family history, slit lamp biomicroscopy, applanation tonometry, detailed funduscopy, 
stereoscopic ophthalmoscopy of the optic disc with a 78-D lens, stereophotographs of the 
optic nerve, optic nerve imaging, and visual field evaluation.
Exclusion criteria—Patients were excluded from the study if they had an eye disease 
other than glaucoma, or if they had a systemic disease known to affect vision, or if they were 
taking medications known to affect visual function.
Structural measurements
Confocal scanning laser ophthalmoscopy scans of the optic nerve head were acquired with 
the Heidelberg Retina Tomograph II (HRT II) (Heidelberg Engineering, Heidelberg, 
Germany). These scans provided quantitative analysis of the neuroretinal RA. The quality of 
the image was evaluated by the HRT software and the researcher who originally collected 
the data.14 The optic disc margin was drawn by a trained technician.
Visual function measurements
SAP was carried out using the Humphrey Field Analyzer II (Carl Zeiss Meditec, Dublin, 
California, USA) with the 24–2 testing strategy to evaluate the central visual field. Size III 
stimuli were presented at 54 locations on a 10-cd/m2 uniform background, as a temporal 
pulse of 200 ms duration. The locations above and below the blind spot were excluded from 
analysis in this study.
Two versions of CSP (CSP-1 and CSP-2) have been developed and were used in this study. 
CSP-1 measurements were carried out using a custom-built system based on a commercial 
visual stimulus generator (VSG2/5, Cambridge Research Systems Ltd.; Cambridge, UK). 
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The technical specifications of this device are described by Hot et al.14 The Gabor patches 
on the VSG had a peak spatial frequency of 0.4 cyc/deg and were presented on a 55-cd/m2 
background with Weber contrast between 100% and 0.1% in 0.15-log unit steps. The stimuli 
were presented with a temporal Gaussian envelope of 600 ms (time constant of 100 ms); 
68% of energy was within the central 200 ms. CSP-1 determines contrast thresholds for 26 
locations over the central visual field, half as many as the 24–2 in order to increase the 
number of trials and allow greater precision for threshold estimation. An area of the visual 
field from 23° nasally to 15° temporally and 17° both superiorly and inferiorly was covered 
by the locations. The central 5° and the area near the typical blind spot were avoided. 
Although SAP and CSP tested similar regions of the visual field, the stimulus locations were 
rarely identical.
CSP-2 used the ViSaGe stimulus generator (Cambridge Research Systems Ltd.; Cambridge, 
UK) to present stimuli similar to those used in CSP-1. Stimuli were presented on a 40-cd/m2 
background at Weber contrasts from 0.7% to 71%.16 The CSP-2 stimuli were sine-wave 
Gabor grating patches with magnification that varied by location: spatial frequency was 0.5 
cycle/deg at fixation, decreasing to 0.14 cycle/deg at 21 degrees, based on spatial scale. 
These sine-wave horizontal gratings were within a two-dimensional Gaussian window 
whose size was increased as spatial frequency decreased to magnify the stimuli accordingly. 
The stimuli were presented with 3 cycles of 5 Hz counterphase square-wave flicker. CSP-2 
presented stimuli at 57 locations similar to the 24–2 locations as shown in Figure 1 of 
reference 16 (one blind spot location was excluded in the analyses).
Structure-function pairs
We selected patients who had at least six visits with HRT, SAP, and CSP-1 from the CSP-1 
dataset and at least six visits with HRT, SAP and CSP-2 from the CSP-2 dataset. At each 
visit, the structural and functional measurements were performed within one month. A 
minimum of 2 months separated each visit. To minimize the impact of learning, we 
performed our analyses on the last five visits only. We used RA as the structural parameter 
and MS, for SAP and CSP, as the functional parameter. Three different combinations of 
structure-function data were assessed: SAP MS and RA, CSP-1 MS and RA, and CSP-2 MS 
and RA.
RA, SAP and CSP data are each expressed in different units. RA is expressed in mm2 (linear 
unit), the sensitivity values are expressed in logarithmic units for CSP-1 and CSP-2 and in 
decibels (10 times logarithmic units) for SAP. In order to make direct comparisons between 
the different measures, we expressed RA and MS in comparable units. We expressed all data 
in percent of mean normal. For SAP and CSP, we first converted the functional data from 
their respective logarithmic units into linear units and then calculated MS by averaging the 
sensitivities at each location. All data (structure and function) were then expressed as 
percent of mean normal14,17 based on mean normal values obtained from independent 
datasets collected on healthy eyes at IU and SUNY which included 118 (RA), 83 (SAP), 107 
(CSP-1), and 52 (CSP-2) healthy eyes.
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The DSF Model
The DSF model is illustrated in Figure 1. It uses two descriptors, the position and the 
velocity vectors.10 The position vector, computed as the centroid of the paired MS and RA 
data, is an estimate of the current state of the disease. The velocity vector, computed as the 
weighted average of the differences in MS and RA values between consecutive visits, 
provides a description of the direction and the rate at which MS and RA are jointly changing 
over time. The direction of the vector indicates whether the structural and functional indices 
are improving or worsening. The length of the velocity vectors provides information about 
the rate of glaucoma progression, with short vectors indicating slower progression and long 
vectors indicating faster progression. The DSF model can predict the values expected at the 
next visit based on the latest position and velocity vectors.
Statistical Analysis
Each combination of structure-function data (SAP MS and RA, CSP-1 MS and RA, and 
CSP-2 MS and RA) were assessed with the DSF and linear regression. In each, the paired 
longitudinal RA and MS data from the first 3 visits were used to predict the RA and MS for 
the 4th visit with the DSF model and with linear regression. Data from the first 4 visits were 
used for the prediction of RA and MS for the 5th visit. Linear regression was fitted 
separately to RA and MS over time. The magnitude of the prediction error in percent of 
mean normal was used to compare the prediction accuracy of the linear regression and DSF 
models. Prediction error is defined as the square root of the sum of the squared differences 
for each dimension of the vector of differences between predicted values and actual 
measurements (L2 norm). We also compared the prediction errors obtained for SAP MS and 
RA with CSP-1 MS and RA, and with CSP-2 MS and RA within the linear regression and 
DSF model. This was done to determine whether using CSP instead of SAP could improve 
the prediction accuracy of the DSF model.
For each model and structure-function pair, we calculated the median PE and the 95% bias-
corrected and accelerated (BCa) bootstrap confidence interval.18 The Wilcoxon signed-rank 
test was used to determine the presence of significant differences between PEs. All analyses 
were carried out using R, and SPSS. Because glaucomatous damage often occurs in a 
localized, rather than in a diffuse pattern, we also performed all analyses in the superior 
temporal (ST) and inferior temporal (IT) sectors. These sectors have been shown to be the 
most adversely impacted by glaucoma. The structural and functional data were matched 
using the Garway-Heath structure-function map.19
RESULTS
Figure 2 shows the median prediction error and confidence intervals for SAP MS and RA 
and CSP-1 MS and RA (left panel) and for SAP MS and RA and CSP-2 MS and RA (right 
panel). The results are shown for global measurements (upper panel), and for measurements 
in IT sector (middle panel) and ST sector (lower panel). Generally, prediction accuracy was 
better for the DSF model (triangles) compared to linear regression (circles) when either SAP 
or CSP were used as the functional test.
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For SAP MS and RA in the CSP-1 dataset (Figure 2, upper-left panel), the median 
prediction errors with DSF (open triangles) for predicting visits 4 and 5 were 6.6% and 8.0% 
of mean normal, respectively. The corresponding values with CSP-1 MS and RA (closed 
triangles) were 7.8% (difference of 1.2% compared to SAP MS and RA; p=0.40) and 8.6% 
of mean normal, (difference of 0.6% compared to SAP MS and RA; p=0.24) respectively. 
The DSF performed better in 63% of the eyes when SAP MS was used compared to CSP-1 
MS when predicting the 4th visit and in 58% of the eyes for the prediction of the 5th visit. 
Using the DSF model (for SAP MS and RA in the CSP-1 dataset), the prediction errors were 
lower by 3.3% (p = 0.06) and 0.9% of mean normal (p = 0.12) compared to linear regression 
(open circles) for visits 4 and 5, respectively. The DSF prediction error was smaller 
compared to linear regression in 74% and 68% of the eyes for the 4th and 5th visits, 
respectively. Using the DSF model (for CSP-1 MS and RA in the CSP-1 dataset), the 
prediction errors were lower by 4.0% (p =0.02) and 1.4% of mean normal (p =0.31) 
compared to linear regression (closed circles) for visits 4 and 5 respectively. The prediction 
error of the DSF model was smaller in 84% and 58% of the eyes for the prediction of the 4th 
and 5th visit, respectively.
Similar results were obtained for the CSP-2 dataset (Figure 2, upper-right panel). For SAP 
MS and RA, the median prediction errors with the DSF model (open triangles) for predicting 
visits 4 and 5 were 9.0% and 6.3% of mean normal, respectively. The corresponding values 
with CSP-2 MS and RA (closed triangles) were 9.9% (difference of 0.9% compared to SAP 
MS and RA; p=0.82) and 7.0% of mean normal (difference of 0.7% compared to SAP MS 
and RA; p=0.48) respectively. As observed in the CSP-1 dataset, the DSF model had lower 
but not significantly different prediction errors for SAP MS than for CSP-2 MS for 
predicting visit 4 and 5. The DSF performed better in 40% of the eyes when SAP MS was 
used compared to CSP-2 MS when predicting the 4th visit and in 60% of the eyes for the 
prediction of the 5th visit. Using the DSF model (for SAP MS and RA in the CSP-2 dataset), 
the prediction errors were lower by 3.7% (p = 0.02) and 4.3% (p = 0.01) compared to linear 
regression (open circles) for visits 4 and 5 respectively. The DSF prediction error was 
smaller compared to linear regression in 75% and 70% of the eyes for the 4th and 5th visits, 
respectively. Using the DSF model (for CSP-2 MS and RA), the prediction errors were lower 
by 5.3% (p =0.001) and 2.4% of mean normal (p =0.01) compared to linear regression 
(closed circles) for visits 4 and 5 respectively. The DSF model did better in 80% of the eyes 
for the prediction of the 4th and 5th visits.
In the IT and ST sectors, using CSP MS as the functional test did not improve the prediction 
accuracy of the DSF model compared with SAP MS. No significant differences were found 
between SAP MS and CSP-1 MS or between SAP MS and CSP-2 MS for either the DSF 
model or linear regression. When comparing the DSF model with linear regression, 
prediction accuracy was similar for these two models in the IT or ST sector. In the IT sector 
and with the CSP-1 dataset (Figure 2, middle-left panel), the prediction error for SAP MS 
and RA was smaller for the DSF model than for linear regression by 4.5% (p=0.003) for 
visit 4 and by 1.1% (p=0.06) for visit 5. And the prediction error for CSP-1 MS and RA was 
smaller for the DSF by 4.7% (p=0.03) for visit 4 and for linear regression by 0.8% (p=0.60) 
for visit 5. In the CSP-2 dataset (Figure 2, middle-right panel), the prediction error for SAP 
MS and RA was smaller for the DSF model by 3.6% (p=0.01) for visit 4 and for linear 
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regression by 0.8% (p=0.09) for visit 5. The prediction error for CSP-2 MS and RA was 
smaller for the DSF model by 0.7% (p=0.004) for visit 4 and by 3.4% (p=0.01) for visit 5. In 
the ST sector and the CSP-1 dataset (Figure 2, lower-left panel), the prediction error for SAP 
MS and RA was smaller for the DSF model than for linear regression by 2.0% (p=0.06) for 
visit 4 and 3.3% (p=0.02) for visit 5. And the prediction error for CSP-1 MS and RA was 
smaller for the DSF model by 4.6% (p=0.02) and 3.9% (p=0.02) for visits 4 and 5, 
respectively. For the CSP-2 dataset (Figure 2, lower-right panel), the prediction error for 
SAP MS and RA was smaller for the DSF model by 6.8% (p=0.003) and 7.2% (p=0.002) for 
visits 4 and 5, respectively. The prediction error for CSP-2 MS and RA was smaller for the 
DSF model by 3.5% (p=0.01) and 2.7% (p=0.01) for visits 4 and 5, respectively.
DISCUSSION
The results of the present study are consistent with those reported in Hu et al10 in that better 
prediction accuracy was observed for the DSF model compared to the ordinary linear-
regression model in short follow-up series when SAP MS and RA were used. Our results 
extend Hu et al’s finding to the infero- and supero-temporal sectors, which are known to be 
more sensitive to glaucoma damage. We also show that the DSF model continues to have 
better prediction accuracy compared to linear regression when CSP is used as the functional 
test instead of SAP. These results suggest that the DSF model, which uses structural and 
functional data jointly, may have an advantage over linear regression for early detection of 
glaucoma progression.
We hypothesized that the lower test-retest variability reported for CSP compared to SAP14 
would further reduce the prediction error of the DSF model. Our results, however, did not 
support this hypothesis. We found that the errors for global, IT, and ST measurements were 
not significantly different when either CSP-1 or CSP-2 were used as the functional test 
compared to SAP. This was observed with both the DSF model and linear regression. 
Overall, the prediction errors obtained when CSP was used as the functional test were equal 
to, or slightly greater than the errors obtained when SAP was used as the functional test. The 
lower test-retest variability for CSP compared to SAP was reported using logarithmic units.
14
 It is possible that transforming the data from logarithmic to linear units resulted in both 
tests in this study having similar test-retest variability. To assess this, we used a different 
approach to express all data in similar units. For both MS and RA, we computed the 
logarithm of the patient’s value divided by the mean normal value. Figure 3 shows the 
median prediction errors for global, IT, and ST measurements after converting SAP, CSP-1, 
and CSP-2 to log units. Compared to when SAP MS was used as the functional parameter, 
the median prediction error was found to be significantly smaller for CSP-1 MS (for linear 
regression) and CSP-2 MS (for both the DSF model and linear regression) in the IT sector 
and for the prediction of visit 4. This result was not, however, found systematically for the 
global and ST sector and for visit 5. Therefore, expressing the data in the logarithmic scale 
did not consistently result in smaller errors when CSP was used as the functional test 
compared to SAP.
The MS for SAP was obtained by averaging the sensitivities at 52 locations, while MS for 
CSP-1 was obtained by averaging sensitivities at 26 locations. Averaging over more 
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locations reduces test-retest variability and it is possible that SAP MS effectively had lower 
test-retest variability compared to CSP-1 in the present study. This could explain the lower 
error obtained when SAP was used as the functional test compared to CSP-1. To test this 
possibility, we replicated our analysis after selecting the same number of locations 
distributed in a similar spatial pattern for both SAP and CSP-1 (see Figure 4). Even when a 
similar number of locations were used for both tests, no significant differences were 
observed between the errors for both the DSF model and linear regression. This is consistent 
with the results we obtained when SAP was used as the functional test compared to CSP-2, 
where the number of locations was slightly greater for CSP-2 (56 locations) than for SAP 
(52 locations). Because CSP-1 and CSP-2 differ in ways other than the number of locations 
they test (placement of the stimuli and varying magnification based on eccentricity), the 
replication of our analyses with a corresponding number of locations between SAP and 
CSP-1 was warranted.
Although CSP has lower test-retest variability compared to SAP, other performance 
characteristics of the test may account for our results. For example, CSP-2 and frequency-
doubling technology perimetry have been shown to yield deeper defects than SAP in mild 
damage, while yielding milder defects in more severely damaged sectors. This has been 
attributed to lower effects of ganglion cell saturation that occur with CSP compared with 
SAP,16 and may result in a faster rate of change for SAP compared to CSP in the early 
stages of the disease. It is possible that this led to a reduction in the relative prediction 
accuracy of CSP compared to SAP when each was used as the functional test in the DSF 
model. The graphs in the left column of Figure 5 show differences in prediction error 
between SAP and CSP-1 (upper row) and CSP-2 (lower row) for global, IT and ST 
measurements as a function of depth of defect on SAP calculated as the average over 4 
visits. Prediction error tended to be greater for CSP-1 than for SAP for deeper depth of 
defect (SAP MS between 25% to 75%) and smaller for shallower defects (SAP MS greater 
than 75%). This is consistent with the observation that CSP defects tend to be deeper than 
SAP defects in mild damage while SAP defects tend to be deeper later in the disease 
process.16 We did not observe, however, the same trend for CSP-2.
In addition to depth of defect, we explored other factors that may explain individual 
differences in prediction error between CSP-1 and CSP-2 and SAP. Fluctuations in the 
height of the hill of vision over tests influence model fits and their prediction ability. We 
would expect lower prediction error for series of visual fields with less fluctuations. These 
fluctuations are translated into variability in global and sectorial MS, which can be 
summarized with the standard deviation (SD) of the residuals of their linear-regression fits. 
The residual SD were obtained from linear regression of MS over time for the first 4 visits. 
The graphs in the middle column of Figure 5 show differences in prediction error as a 
function of differences in residual SD of the linear regression fits for MS over time. Another 
factor that may explain individual differences in prediction error is the signal-to-noise ratio 
of the fitted models, or equivalently, the ratio of explained to unexplained variance of the 
model fitted to the series. For linear regression, the signal-to-noise ratio is summarized by 
the F-statistic. We would expect lower prediction error for greater F-values of the linear 
regression with MS. We calculated the F-values from linear regression of MS over time for 
the first 4 visits. The graphs in the right column of Figure 5 show differences in prediction 
Ramezani et al. Page 8
J Glaucoma. Author manuscript; available in PMC 2019 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
error as a function of differences in F-values of the linear regression fits for MS over time. 
There does not seem to be any clear association between differences in residual SD or in F-
values and differences in prediction error. Therefore, test-retest variability influenced by 
fluctuations in the hill of vision, and signal-to-noise ratio do not explain individual 
differences in prediction error for CSP-1 and CSP-2 against SAP.
We used the 2002 Garway-Heath map19 to determine which visual field locations 
correspond to the IT and ST sectors. We then averaged these locations without addressing 
the fact that some visual field locations are situated on the same nerve fiber bundle and 
therefore enter the optic nerve head at the same location (for example, see the two locations 
circled in the left panel of Figure 6). These visual field locations do not contribute 
independent information and ideally, they should have been weighed to reflect this. We 
therefore used the information provided in Figure 4 of Garway-Heath et al’s paper20 to 
develop weights for each visual field location in the ST and IT sectors. The right panel of 
Figure 6 shows that the angle at which the bundles of each visual field location enter the 
optic nerve head are unevenly distributed. We derived the weights by determining the 
number of optic nerve head degrees represented by each visual field location. When two 
visual field locations entered the disc at the same degree, the contribution of each of these 
visual field locations were halved. The MS at each location was multiplied by its 
corresponding weight and then divided by 45 (the total span in degrees of each of the ST and 
IT sectors). We reran all SAP MS and RA analyses using the weighted MS and found that 
the differences in median prediction error for weighted and unweighted SAP MS were small 
(always lower than 3.2%). Finally, while we used the Garway-Heath map in this study, other 
maps are also available. We therefore replicated the weighted analyses using the Jansonius 
map21 as implemented in the open source R package visualFields.22 Figure 7 shows the 
median prediction errors (and 95% confidence intervals) for the IT and ST sectors using 
weighted MS based on the Garway-Heath map (solid symbols) and the Jansonius map 
(empty symbols). There were no clear systematic differences between the maps for the IT or 
ST sectors, among visits and datasets. Both the Garway-Heath and the Jansonius maps use 
average nerve fiber bundle trajectories to determine the optic nerve head location for each 
test point in the visual field. But given the large inter-individual anatomical differences 20 
the test points included in the IT and ST sectors would likely be different if we had access to 
individualized maps for each eye.
In this study, we did not exclude functional data based on reliability in the primary analysis 
because of possible differences in reliability indices between CSP and SAP. For example, the 
stimuli used to test the blind spot in CSP-1 (~2° of visual angle) and CSP-2 (~3°) are much 
larger than the Goldman size III stimulus used in SAP (~0.4°). The proportion of fixation 
losses obtained with CSP-1 and CSP-2 may therefore be greater for CSP than for SAP. To 
assess the impact of reliability, we performed a secondary analysis which included only data 
with false-positive rate lower than 33% for all perimetric tests and HRT images with 
standard deviation of height measure of less than 50 μm. We did not consider false negative 
errors because these can occur in glaucoma patients who perform reliably.23 Three patients 
in the CSP-1 dataset (false-positive errors, n=2; HRT height measure standard deviation, 
n=1) and one patient from the CSP-2 dataset (due to HRT height measure standard 
deviation) did not meet these criteria. An average reduction of approximately 1% of mean 
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normal in prediction error was observed for CSP-1 compared to SAP for both ordinary linear 
regression and the DSF model. The greater decrease in prediction error for CSP-1 than for 
SAP considering reliability resulted in more similar results between their median prediction 
errors. For CSP-2, the average reduction was less than 0.4% of mean normal in prediction 
error compared to SAP, which resulted in even smaller median error for CSP-2 than for SAP.
In summary, the findings of this study show similar prediction accuracy when SAP and CSP 
are used as the functional test within the DSF model. The established lower test-retest 
variability for CSP-1 and CSP-2 compared to SAP in glaucomatous eyes did not translate 
into better prediction accuracy within the framework of the DSF model. Signal-to-noise ratio 
and the impact of test-retest variability on the hill of vision accounted only for a modest 
percentage of the differences observed in prediction error between SAP and CSP.
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Figure 1. 
The position and velocity vectors are represented by the red circle and the red arrow, 
respectively. The red dashed lines are used to illustrate that both vectors were obtained from 
the MS and RA values of the first 4 visits (denoted by the numerals 1 to 4). The red numeral 
5 represents the predicted values of MS and RA at the 5th visit and is derived from the 
position and velocity vectors estimated with the DSF model. The prediction error is the 
distance between the predicted (red numeral 5) and the observed (black numeral 5) values of 
the 5th visit.
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Figure 2. 
Median prediction errors (and 95% BCa confidence intervals) for visits 4 and 5 for global 
SAP MS and RA and CSP-1 MS and RA (n=19) (left panel), and for SAP MS and RA and 
CSP-2 MS and RA (n=20) (right panel). Results are shown for the DSF model (triangles) 
and linear regression (circles). The upper panel corresponds to global measurement; the 
middle and lower panels show the results for IT and ST sectors respectively.
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Figure 3. 
Median prediction errors of global (upper panel), for the IT sector (middle panel), and the 
ST sector (lower panel) for % of mean normal based on dB (SAP) and log unit (CSP-1 and 
CSP-2) scales. Other details as in Figure 2.
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Figure 4. 
Pattern of testing location for 24–2 SAP (gray dots) and for CSP-1 (open black circles). The 
locations selected for both tests are marked with red circles. Thirty locations were removed 
from the SAP 24–2 test before calculating MS and only two locations (marked with red 
crosses) were removed from the CSP-1 because they did not overlap with a corresponding 
SAP test location.
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Figure 5. 
Differences in prediction error as a function of SAP MS (left column), differences in 
residual SD (middle column), and differences in F-values (signal-to-noise ratio; right 
column) for global and IT and ST sectors. CSP-1 or CSP-2 depth of defect in the graphs on 
the left column are shown with a gray scale with darker shades of gray representing smaller 
values. The differences in residual SD and F-values in the middle and right columns are 
between CSP-1 or CSP-2 and SAP. Note: Three points from the upper right graph were 
removed for clarity since the differences in F-values were disproportionally large at −190 
and −637 (ST), and 417 (IT). The differences in prediction error for these three points were 
−4%, −16%, and −42%. Three points from the lower right graph were also removed for 
clarity. The differences in F-values of the removed points were 93 and 114 (global), and 143 
(ST). The differences in prediction error for these three points were −10%, −2%, and −14%.
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Figure 6. 
The angle along the optic nerve head at which the nerve fiber bundles associated with each 
visual field location is shown in the left panel for the Garway-Heath map (black) and the 
Jansonius map (red). The bolded locations are those included in the IT and ST sectors. The 
visual field locations associated with the IT and ST sectors are not identical for the two 
maps; the arrows indicate visual field locations included in one sector with one map, but 
excluded from that sector with the other map. The two circles provide an example of two 
visual field locations served by the same nerve fiber bundle (same angle of entry into the 
optic nerve head). Weights were applied to the sectoral mean sensitivity, to avoid over-
contribution to the MS of visual field locations served by the same bundle. The right panel 
shows how these weights were derived. Each visual field location located in the IT and ST 
sectors is mapped based on its angle of entry into the optic nerve head (short bars represent a 
single visual field location and tall bars represent two visual field locations). The distribution 
of entry points is uneven and less weight is given to visual field locations that have entry 
points near to each other. Once each visual field was mapped onto the optic nerve head 
based on its angle of entry, the midpoints between the angles (vertical light gray bars) were 
determined. A visual field location received a weight of 10 if the bundles of no other visual 
field locations entered the optic nerve within 10 degrees of it (as shown for the visual field 
location whose bundle enters the optic nerve head at 312° in the upper right section of the 
right panel). When two visual field locations were served by the same bundle, the weight 
was derived in the same way, but divided by two such that each visual field location was not 
over-represented.
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Figure 7. 
Median prediction errors for the IT (upper panel) and the ST (lower panel) sectors as defined 
with the Garway-Heath map (solid symbols) and the Jansonius map (empty symbols) for 
SAP MS and RA in the CSP-1 (left panel) and the CSP-2 (right panel) datasets for linear 
regression (circles) and the DSF model (triangles). Other details as in Figure 2.
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